Steven Rosen, MD, from the City of Hope, Duarte, CA, discusses the remarkable quantity and quality of information on blood cancer therapeutics that has been collected and presented at the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2018 meeting, held in Nice, France. Dr Rosen expresses how it seems that we are very nearly approaching a cure for certain hematological malignancies, with the introduction of CAR T-cell therapy, bispecific antibodies and targeted therapies; all of which are producing promising results in clinical trials.
Non-hodgkin lymphoma advances in 2018
